Terns Pharmaceuticals Correlations

TERN Stock

USD 3.32 0.19 5.41%

The current 90-days correlation between Terns Pharmaceuticals and Amylyx Pharmaceuticals is 0.49 (i.e., Very weak diversification). A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Terns Pharmaceuticals moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Terns Pharmaceuticals moves in either direction, the perfectly negatively correlated security will move in the opposite direction.

Terns Pharmaceuticals Correlation With Market

Modest diversification

The correlation between Terns Pharmaceuticals and DJI is 0.23 (i.e., Modest diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Terns Pharmaceuticals and DJI in the same portfolio, assuming nothing else is changed.

Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Terns Pharmaceuticals. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area.

To learn how to invest in Terns Stock, please use our How to Invest in Terns Pharmaceuticals guide.

Moving together with Terns Stock

0.84	CDIOW	Cardio Diagnostics	Pair Corr
0.87	VINC	Vincerx Pharma Earnings Call This Week	Pair Corr
0.83	ELVN	Enliven Therapeutics Downward Rally	Pair Corr
0.79	GPCR	Structure Therapeutics	Pair Corr
0.94	ZURA	Zura Bio Limited	Pair Corr
0.82	IMMX	Immix Biopharma	Pair Corr
0.62	IMRX	Immuneering Corp	Pair Corr
0.95	MLTX	MoonLake Immunotherapeuti	Pair Corr
0.86	PMVP	Pmv Pharmaceuticals	Pair Corr
0.86	PYXS	Pyxis Oncology	Pair Corr
0.82	SCLX	Scilex Holding	Pair Corr
0.84	ASMB	Assembly Biosciences Earnings Call Tomorrow	Pair Corr
0.82	ATNF	180 Life Sciences	Pair Corr
0.61	AVTE	Aerovate Therapeutics	Pair Corr
0.64	BIIB	Biogen Inc	Pair Corr

Moving against Terns Stock

0.91	SNY	Sanofi ADR	Pair Corr
0.88	AZN	AstraZeneca PLC ADR	Pair Corr
0.81	GILD	Gilead Sciences Potential Growth	Pair Corr
0.76	GOSS	Gossamer Bio	Pair Corr
0.68	OCX	OncoCyte Corp	Pair Corr
0.67	PLX	Protalix Biotherapeutics	Pair Corr
0.61	LLY	Eli Lilly	Pair Corr
0.58	BMY	Bristol Myers Squibb	Pair Corr
0.89	AMGN	Amgen Inc	Pair Corr
0.78	NVCT	Nuvectis Pharma	Pair Corr
0.76	DRMAW	Dermata Therapeutics	Pair Corr
0.6	CMPX	Compass Therapeutics	Pair Corr
0.5	RVP	Retractable Technologies Earnings Call This Week	Pair Corr

Related Correlations Analysis

	AMLX	ABOS	INZY	XFOR	MREO	PDSB	HOOK	DAWN	ELDN
AMLX		0.55	0.66	0.46	0.57	0.62	0.21	0.24	0.18	AMLX
ABOS	0.55		0.86	0.84	0.89	0.87	0.82	0.8	0.53	ABOS
INZY	0.66	0.86		0.82	0.89	0.81	0.58	0.59	0.39	INZY
XFOR	0.46	0.84	0.82		0.88	0.84	0.78	0.81	0.69	XFOR
MREO	0.57	0.89	0.89	0.88		0.79	0.72	0.74	0.53	MREO
PDSB	0.62	0.87	0.81	0.84	0.79		0.72	0.7	0.59	PDSB
HOOK	0.21	0.82	0.58	0.78	0.72	0.72		0.94	0.74	HOOK
DAWN	0.24	0.8	0.59	0.81	0.74	0.7	0.94		0.81	DAWN
ELDN	0.18	0.53	0.39	0.69	0.53	0.59	0.74	0.81		ELDN
	AMLX	ABOS	INZY	XFOR	MREO	PDSB	HOOK	DAWN	ELDN

Click cells to compare fundamentals

Check Volatility

Backtest Portfolio

Risk-Adjusted Indicators

There is a big difference between Terns Stock performing well and Terns Pharmaceuticals Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Terns Pharmaceuticals' multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.

	Mean Deviation	Jensen Alpha	Treynor Ratio	Potential Upside	Value @Risk	Maximum Drawdown
AMLX	3.67	0.00	(0.04)	7.20	(9.09)	21.45
ABOS	3.02	(0.59)	(0.49)	6.57	(7.09)	19.77
INZY	4.12	(1.40)	(0.80)	6.82	(9.17)	36.29
XFOR	6.28	(0.68)	(2.46)	10.87	(13.51)	68.45
MREO	2.63	(0.41)	(0.56)	6.16	(6.13)	20.77
PDSB	4.46	(0.33)	(0.46)	9.21	(9.22)	33.91
HOOK	3.63	(0.76)	(8.73)	7.00	(7.50)	32.80
DAWN	2.88	(0.52)	(0.61)	6.36	(6.67)	22.86
ELDN	2.75	(0.22)	(0.18)	4.71	(5.28)	18.63

Terns Pharmaceuticals Corporate Management

David Strauss	VP Controller	Profile
Pamela Danagher	Senior Assurance	Profile
Debra Sieminski	Senior Affairs	Profile
Jeffrey Jasper	Senior Research	Profile
JD Esq	Chief Officer	Profile
Senthil Sundaram	CEO Director	Profile

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC